Synopsis

Keywords: Cardiovascular: Cardiac, Cardiovascular: Myocardium, Cardiovascular: Hemodynamics

Cardiovascular MRI (CMR) is meanwhile used in clinical routine to diagnose different disease, but also to guide therapeutic decision making. In the Guidelines of the European Society of Cardiology CMR plays an increasing role for the assessment of ischemic as well as non-ischemic heart diseases. Most of the clinical decisions are based on quantitative parameters describing the function and morphology of the heart as well as the myocardial tissue properties and hemodynamic parameter of the vessels. To provide reliable and meaningful results a quality assurance is mandatory.

Acknowledgements

No acknowledgement found.

References

Cardiovascular MRI (CMR) is meanwhile used in clinical routine to diagnose different disease, but also to guide therapeutic decision making. In the Guidelines of the European Society of Cardiology CMR plays an increasing role for the assessment of ischemic as well as non-ischemic heart diseases. Most of the clinical decisions are based on quantitative parameters describing the function and morphology of the heart as well as the myocardial tissue properties and hemodynamic parameter of the vessels. To provide reliable and meaningful results a quality assurance is mandatory. The talk will discuss the quantitative parameter needed in clinical routine today and those one needed in future. Furthermore, potential confounders will be introduced and possibilities to control or influence them. There is huge need for a close interaction of scientists and clinicians to overcome these challenges.